Saturday 17 October 2026
Export NEPTF’s income statement to Excel — free account
Neptune Wellness Solutions Inc.
NEPTF Healthcare Drug Manufacturers Specialty & Generic
Revenue growth for five consecutive years, operating cash flow growth for five.
0.00
0.00
NaN
Follow NEPTF
| Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Feb '16 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 2 | 2 | 3 | 5 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 70.08 | 25.26 | 0.00 | 0.00 |
P/S ratio |
0.12 | 0.77 | 4.49 | 4.74 | 13.73 | 6.27 | 2.26 | 4.14 | 6.48 |
Altman Z-Score |
(27.25) | (6.04) | (1.70) | (0.71) | 7.33 | 13.61 | 68.62 | — | 0.36 |
Altman Z″-Score (non-manufacturers) |
(66.99) | (13.82) | (4.19) | (2.49) | (1.66) | 6.74 | (0.53) | (2.25) | (0.81) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(0.81) | (3.57) | (15.93) | (24.32) | (101.10) | (1,011.84) | (364.69) | (25.90) | 201.21 |
Beneish M-Score |
— | — | — | — | (3.63) | (2.19) | (1.96) | — | — |
P/B ratio |
0.00 | 0.62 | 1.15 | 0.98 | 4.86 | 4.08 | 1.47 | 1.50 | 1.75 |
Price to Tangible BV |
0.00 | 2.21 | 1.84 | 1.85 | 6.15 | 5.57 | 2.01 | 1.89 | 1.79 |
EV/Sales |
0.52 | 0.83 | 3.12 | 4.32 | 13.48 | 6.62 | 2.61 | 4.90 | 6.03 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 37.82 | 14.93 | 0.00 | 0.00 |
EV/Operating CF |
(0.96) | (0.75) | (1.95) | (4.06) | (40.40) | (160.43) | (63.32) | (10.29) | (3.02) |
EV/FCF |
(0.89) | (0.72) | (1.74) | (2.80) | (19.10) | (71.85) | (28.36) | (9.31) | (1.84) |
Quick Ratio |
0.23 | 0.54 | 1.97 | 1.59 | 0.78 | 2.80 | 1.66 | 1.30 | 1.30 |
Current Ratio |
0.57 | 1.23 | 2.57 | 2.25 | 1.23 | 3.29 | 2.44 | 2.34 | 2.34 |
Net Debt/EBITDA |
(0.21) | (0.04) | 0.43 | 0.09 | 0.32 | (4.72) | (1.71) | (1.10) | (1.20) |
Debt/Assets |
74.21% | 11.59% | 6.15% | 2.33% | 3.84% | 4.73% | 21.88% | 26.10% | 26.10% |
Debt/Equity |
(0.83) | 0.20 | 0.08 | 0.03 | 0.05 | 0.05 | 0.38 | 0.52 | 0.41 |
Asset Turnover |
0.77 | 0.33 | 0.23 | 0.23 | 0.26 | 0.27 | 0.39 | 0.21 | 0.43 |
Operating CF/Net income |
0.47 | 0.72 | 0.46 | 0.52 | 0.35 | (0.43) | 0.89 | 1.63 | 1.53 |
Capex/Depreciation |
(0.28) | (0.39) | (0.37) | (1.70) | (3.03) | 10.92 | 0.00 | 0.00 | (0.52) |
Interest Coverage |
(26.90) | (41.29) | (73.24) | (265.43) | (50.13) | 0.48 | (277.81) | (299.51) | (10.23) |
| (363.37%) | (75.58%) | (100.33%) | (57.00%) | (29.43%) | 23.70% | 10.76% | (12.46%) | (9.36%) | |
| (88.99%) | (51.37%) | (78.49%) | (46.78%) | (24.26%) | 17.04% | 5.80% | (7.07%) | (14.09%) | |
ROIC |
0.00% | (86.11%) | (91.71%) | (73.94%) | (22.78%) | 1.13% | 0.00% | 0.00% | (11.33%) |
Return on Tangible Assets |
375.98% | (262.88%) | (133.79%) | (74.58%) | (44.87%) | 25.67% | 8.92% | (10.64%) | (10.64%) |
Average Days of Receivables |
52.08 | 56.84 | 89.36 | 133.20 | 86.71 | 74.47 | 115.70 | 175.21 | 175.21 |
Research and Development Expense of Revenue |
0.92% | 1.80% | 5.43% | 9.70% | 29.50% | 51.18% | 10.15% | 28.92% | 29.07% |
Selling, General and Administrative Expense of Revenue |
88.23% | 124.06% | 180.29% | 218.62% | 62.54% | 53.20% | 33.62% | 59.36% | 61.89% |
Intangible Assets out of Total Assets |
0.13 | 0.42 | 0.28 | 0.40 | 0.16 | 0.12 | 0.17 | 0.13 | 0.13 |
Share Based Compensation of Revenue |
6.66% | 16.02% | 27.92% | 56.10% | 15.19% | 8.26% | 0.00% | 0.00% | 7.25% |
Graham Net Nets |
(5.48) | (0.18) | 0.25 | 0.10 | 0.01 | 0.00 | 0.00 | 0.01 | 0.14 |
Graham Number |
757.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,264.81%) | (193.36%) | (77.02%) | (41.84%) | (7.16%) | 1.43% | 3.96% | (2.54%) | (7.62%) |
Free Cash Flow Yield |
(480.73%) | (151.05%) | (40.07%) | (32.62%) | (5.14%) | (1.47%) | (4.08%) | (12.73%) | (50.63%) |
Revenue per Share |
178.18 | 404.62 | 408.78 | 345.83 | 327.33 | 383.79 | 14.59 | 0.00 | 320.36 |
Operating CF per Share |
(96.73) | (450.63) | (654.11) | (367.49) | (109.20) | (105.32) | 1.91 | 0.00 | (161.30) |
Capex per Share |
(2.58) | (19.66) | (80.75) | (166.80) | (121.74) | 527.88 | 0.00 | 0.00 | (18.39) |
Free Cash Flow per Share |
(99.31) | (470.30) | (734.86) | (534.29) | (230.95) | 422.56 | 1.91 | 0.00 | (179.70) |
Cash per Share |
6.81 | 72.52 | 691.18 | 194.24 | 132.14 | 369.79 | 5.34 | 0.00 | 184.01 |
Shareholders Equity per Share |
(93.33) | 504.46 | 1,588.28 | 1,679.34 | 923.84 | 1,201.31 | 21.52 | 0.00 | 947.32 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(93.33) | 504.46 | 1,588.28 | 1,679.34 | 923.84 | 1,201.31 | 21.52 | 0.00 | 947.32 |
Free Cash Flow |
(29.33) | (56.72) | (63.64) | (34.35) | (13.14) | 23.75 | 4.26 | (9.43) | (9.74) |
Working Capital |
(17.48) | 7.07 | 54.72 | 16.22 | 3.55 | 20.61 | 19.25 | 19.07 | 18.94 |
Capital Expenditures |
(0.76) | (2.37) | (6.99) | (10.73) | (6.93) | 29.67 | (3.50) | (1.00) | (1.00) |
Net Current Asset Value |
(34.94) | (6.73) | 40.13 | 10.26 | 2.59 | 20.18 | 5.20 | 3.05 | 3.03 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.47 | 24.65 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.05 | 0.20 | 0.48 | 0.37 | (1.38) | 0.00 | 0.00 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 59.12 | 21.31 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.94 | 0.28 | 0.51 | 0.14 | 0.06 | 0.08 | 0.08 | 0.06 | 0.06 |
Cash ROIC |
1,128.56% | (69.38%) | (30.46%) | (27.84%) | (20.95%) | 25.83% | 5.45% | (12.97%) | (11.80%) |
Accounts Receivable Turnover |
6.97 | 6.00 | 4.22 | 3.55 | 4.22 | 2.93 | 3.48 | 2.09 | 2.08 |
Accounts Payable Turnover |
2.21 | 2.65 | 4.29 | 2.98 | 2.18 | 3.90 | 6.47 | 2.41 | 1.94 |
Inventory Turnover |
3.66 | 3.28 | 5.20 | 4.43 | 3.23 | 2.37 | 2.06 | 1.03 | 1.00 |
Average Days of Payables |
179.23 | 147.09 | 115.60 | 144.67 | 184.79 | 115.52 | 48.30 | 111.03 | 198.37 |
Days of Inventory on Hand |
86.17 | 110.53 | 100.69 | 105.64 | 109.28 | 90.07 | 147.22 | 356.09 | 366.11 |
Average Receivables |
7.55 | 8.13 | 8.39 | 6.27 | 4.41 | 7.35 | 9.35 | 8.36 | 8.34 |
Average Payables |
24.88 | 21.29 | 14.62 | 7.93 | 5.88 | 4.27 | 3.82 | 5.95 | 7.16 |
Average Inventory |
15.03 | 17.19 | 12.08 | 5.34 | 3.97 | 7.03 | 11.98 | 13.95 | 13.90 |
Average Assets |
67.94 | 145.95 | 156.92 | 97.82 | 72.84 | 80.27 | 82.77 | 81.64 | 40.68 |
Average Common Equity |
16.64 | 99.19 | 122.76 | 80.27 | 60.04 | 57.72 | 44.61 | 46.32 | 61.20 |
Columns are period end dates